Clinical Trial Update: RhBMP-2 in Intrabony Defects - A Randomized Controlled Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized controlled trial evaluating RhBMP-2 in intrabony defects for periodontitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• rhBMP-2 (bone morphogenetic protein-2)

Snippet

Sponsor: SVS Institute of Dental Sciences | Conditions: Periodontitis | Phase 2 | Status: COMPLETED